{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:01:36Z","timestamp":1774929696616,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Cognitive behavioral therapy (CBT) and U.S. Food and Drug Administration (FDA)-recommended pharmacologic treatments (RPTs; pregabalin, duloxetine, and milnacipran) are effective treatment options for fibromyalgia (FM) syndrome and are currently recommended by clinical guidelines. We compared the cost-utility from the healthcare and societal perspectives of CBT versus RPT (combination of pregabalin + duloxetine) and usual care (TAU) groups in the treatment of FM.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The economic evaluation was conducted alongside a 6-month, multicenter, randomized, blinded, parallel group, controlled trial. In total, 168 FM patients from 41 general practices in Zaragoza (Spain) were randomized to CBT (<jats:italic>n<\/jats:italic> = 57), RPT (<jats:italic>n<\/jats:italic> = 56), or TAU (<jats:italic>n<\/jats:italic> = 55). The main outcome measures were Quality-Adjusted Life Years (QALYs, assessed by using the EuroQoL-5D questionnaire) and improvements in health-related quality of life (HRQoL, assessed by using EuroQoL-5D visual analogue scale, EQ-VAS). The costs of healthcare use were estimated from patient self-reports (Client Service Receipt Inventory). Cost-utility was assessed by using the net-benefit approach and cost-effectiveness acceptability curves (CEACs).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>On average, the total costs per patient in the CBT group (1,847\u20ac) were significantly lower than those in patients receiving RPT (3,664\u20ac) or TAU (3,124\u20ac). Patients receiving CBT reported a higher quality of life (QALYs and EQ-VAS scores); the differences between groups were significant only for EQ-VAS. From a complete case-analysis approach (base case), the point estimates of the cost-effectiveness ratios resulted in dominance for the CBT group in all of the comparisons performed, by using both QALYs and EQ-VAS as outcomes. These findings were confirmed by bootstrap analyses, net-benefit curves, and CEACs. Two additional sensitivity analyses (intention-to-treat analysis and per-protocol analysis) indicated that the results were robust. The comparison of RPT with TAU yielded no clear preference for either treatment when using QALYs, although RPT was determined to be more cost-effective than TAU when evaluating EQ-VAS.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Because of lower costs, CBT is the most cost-effective treatment for adult FM patients. Implementation in routine medical care would require policymakers to develop more-widespread public access to trained and experienced therapists in group-based forms of CBT.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial registration<\/jats:title>\n                        <jats:p>Current Controlled Trials <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.controlled-trials.com\/ISRCTN10804772\/\">ISRCTN10804772<\/jats:ext-link>. Registered 29 September 2008.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0451-y","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T10:38:55Z","timestamp":1412073535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Juan V","family":"Luciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cerd\u00e0-Lafont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda T","family":"Pe\u00f1arrubia-Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio I","family":"Cuesta-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Serrano-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garc\u00eda-Campayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"451_CR1","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.36076\/ppj.2011\/14\/E217","volume":"14","author":"HS Smith","year":"2011","unstructured":"Smith HS, Harris R, Clauw D: Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011, 14: E217-E245.","journal-title":"Pain Physician"},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clar P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172. 10.1002\/art.1780330203.","journal-title":"Arthritis Rheum"},{"key":"451_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010, 62: 600-610. 10.1002\/acr.20140.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"451_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP: Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013, 17: 356-10.1007\/s11916-013-0356-5.","journal-title":"Curr Pain Headache Rep"},{"key":"451_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/15360288.2012.736933","volume":"26","author":"RM Leadley","year":"2012","unstructured":"Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J: Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. J Pain Palliat Care Pharmacother. 2012, 26: 310-325. 10.3109\/15360288.2012.736933.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"451_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/CEOR.S41111","volume":"5","author":"T Knight","year":"2013","unstructured":"Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S: Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013, 5: 171-180. 10.2147\/CEOR.S41111.","journal-title":"Clinicoecon Outcomes Res"},{"key":"451_CR7","first-page":"16","volume":"11","author":"M Briley","year":"2009","unstructured":"Briley M: Drugs to treat fibromyalgia: the transatlantic difference. Curr Opin Investig Drugs. 2009, 11: 16-18.","journal-title":"Curr Opin Investig Drugs"},{"key":"451_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","volume":"145","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, \u00dc\u00e7eyler N, Sommer C: Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials. Pain. 2009, 145: 69-81. 10.1016\/j.pain.2009.05.014.","journal-title":"Pain"},{"key":"451_CR9","volume-title":"Cochrane Database Syst Rev","author":"N U\u00e7eyler","year":"2013","unstructured":"U\u00e7eyler N, Sommer C, Walitt B, H\u00e4user W: Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013, 10:"},{"key":"451_CR10","volume-title":"Cochrane Database Syst Rev","author":"W H\u00e4user","year":"2013","unstructured":"H\u00e4user W, Urr\u00fatia G, Tort S, U\u00e7eyler N, Walitt B: Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2013, 1:"},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","volume":"72","author":"E N\u00fcesch","year":"2013","unstructured":"N\u00fcesch E, H\u00e4user W, Bernardy K, Barth J, J\u00fcni P: Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013, 72: 955-962. 10.1136\/annrheumdis-2011-201249.","journal-title":"Ann Rheum Dis"},{"key":"451_CR12","volume-title":"Cochrane Database Syst Rev","author":"AC Williams","year":"2012","unstructured":"Williams AC, Eccleston C, Morley S: Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012, 11:"},{"key":"451_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1586\/14737175.2013.846517","volume":"13","author":"N Sehgal","year":"2013","unstructured":"Sehgal N, Colson J, Smith HS: Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Rev Neurother. 2013, 13: 1201-1220. 10.1586\/14737175.2013.846517.","journal-title":"Expert Rev Neurother"},{"key":"451_CR14","volume-title":"Cochrane Database Syst Rev","author":"K Bernardy","year":"2013","unstructured":"Bernardy K, Klose P, Busch AJ, Choy EH, H\u00e4user W: Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013, 9:"},{"key":"451_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1517\/14656566.7.8.1027","volume":"7","author":"RL Robinson","year":"2006","unstructured":"Robinson RL, Jones ML: In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review. Expert Opin Pharmacother. 2006, 7: 1027-1039. 10.1517\/14656566.7.8.1027.","journal-title":"Expert Opin Pharmacother"},{"key":"451_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1185\/03007991003600271","volume":"26","author":"E Choy","year":"2010","unstructured":"Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G: Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. Curr Med Res Opin. 2010, 26: 965-975. 10.1185\/03007991003600271.","journal-title":"Curr Med Res Opin"},{"key":"451_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3111\/13696998.2012.660254","volume":"15","author":"A Lloyd","year":"2012","unstructured":"Lloyd A, Boomershine CS, Choy EH, Chandran A, Zlateva G: Cost effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. J Med Econ. 2012, 15: 481-492. 10.3111\/13696998.2012.660254.","journal-title":"J Med Econ"},{"key":"451_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3111\/13696998.2011.586389","volume":"14","author":"SM Beard","year":"2011","unstructured":"Beard SM, Roskell N, Le TK, Zhao Y, Coleman A, Ang D, Lawson K: Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States. J Med Econ. 2011, 14: 463-476.","journal-title":"J Med Econ"},{"key":"451_CR19","first-page":"1246","volume":"23","author":"ME Goossens","year":"1996","unstructured":"Goossens ME, Rutten-van M\u00f6lken MP, Leidl RM, Bos SG, Vlaeyen JW, Teeken-Gruben NJ: Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II. Economic evaluation. J Rheumatol. 1996, 23: 1246-1254.","journal-title":"J Rheumatol"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/rheumatology\/kem157","volume":"46","author":"TR Zijlstra","year":"2007","unstructured":"Zijlstra TR, Braakman-Jansen LM, Taal E, Rasker JJ, van de Laar MA: Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free. Rheumatology (Oxford). 2007, 46: 1454-1459. 10.1093\/rheumatology\/kem157.","journal-title":"Rheumatology (Oxford)"},{"key":"451_CR21","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/ar2377","volume":"10","author":"N Gusi","year":"2008","unstructured":"Gusi N, Tom\u00e1s-Car\u00fas P: Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial. Arthritis Res Ther. 2008, 10: R24-10.1186\/ar2377.","journal-title":"Arthritis Res Ther"},{"key":"451_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/AJP.0b013e318270f99a","volume":"29","author":"JV Luciano","year":"2013","unstructured":"Luciano JV, Sabes-Figuera R, Carde\u00f1osa E, T Pe\u00f1arrubia-Mar\u00eda M, Fern\u00e1ndez-Vergel R, Garc\u00eda-Campayo J, Knapp M, Serrano-Blanco A: Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial. Clin J Pain. 2013, 29: 702-711. 10.1097\/AJP.0b013e318270f99a.","journal-title":"Clin J Pain"},{"key":"451_CR23","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1186\/ar3496","volume":"13","author":"M Alda","year":"2011","unstructured":"Alda M, Luciano JV, Andr\u00e9s E, Serrano-Blanco A, Rodero B, L\u00f3pez Del Hoyo Y, Roca M, Moreno S, Magall\u00f3n R, Garc\u00eda-Campayo J: Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial. Arthritis Res Ther. 2011, 13: R173-10.1186\/ar3496.","journal-title":"Arthritis Res Ther"},{"key":"451_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s13142-011-0107-2","volume":"2","author":"C Rini","year":"2012","unstructured":"Rini C, Williams DA, Broderick JE, Keefe FJ: Meeting them where they are: using the Internet to deliver behavioral medicine interventions for pain. Transl Behav Med. 2012, 2: 82-92. 10.1007\/s13142-011-0107-2.","journal-title":"Transl Behav Med"},{"key":"451_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1745-6215-10-24","volume":"10","author":"J Garc\u00eda-Campayo","year":"2009","unstructured":"Garc\u00eda-Campayo J, Serrano-Blanco A, Rodero B, Magall\u00f3n R, Alda M, Andr\u00e9s E, Luciano JV, L\u00f3pez del Hoyo Y: Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials. 2009, 10: 24-10.1186\/1745-6215-10-24.","journal-title":"Trials"},{"key":"451_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pain.2010.02.018","volume":"149","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliom\u00e4ki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C: Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010, 149: 177-193. 10.1016\/j.pain.2010.02.018.","journal-title":"Pain"},{"key":"451_CR27","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: c332-10.1136\/bmj.c332.","journal-title":"BMJ"},{"key":"451_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1741-7015-11-80","volume":"11","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E: Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med. 2013, 11: 80-10.1186\/1741-7015-11-80.","journal-title":"BMC Med"},{"key":"451_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pain.2005.06.018","volume":"117","author":"SL Yates","year":"2005","unstructured":"Yates SL, Morley S, Eccleston C, Williams A: A scale for rating the quality of psychological trials for pain. Pain. 2005, 117: 314-325. 10.1016\/j.pain.2005.06.018.","journal-title":"Pain"},{"key":"451_CR30","first-page":"34","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59: 34-57.","journal-title":"J Clin Psychiatry"},{"key":"451_CR31","volume-title":"M.I.N.I. Mini International Neuropsychiatric Interview. Versi\u00f3n en Espa\u00f1ol 5.0.0 DSM-IV","author":"L Ferrando","year":"1998","unstructured":"Ferrando L, Soto M, Bobes J, Soto O, Franco L, Gubert J: M.I.N.I. Mini International Neuropsychiatric Interview. Versi\u00f3n en Espa\u00f1ol 5.0.0 DSM-IV. 1998, Instituto IAP, Madrid"},{"key":"451_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1023\/A:1008894502042","volume":"7","author":"X Badia","year":"1998","unstructured":"Badia X, Schiaffino A, Alonso J, Herdman M: Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res. 1998, 7: 311-322. 10.1023\/A:1008894502042.","journal-title":"Qual Life Res"},{"key":"451_CR33","first-page":"79","volume":"112","author":"X Badia","year":"1999","unstructured":"Badia X, Roset M, Montserrat S, Herdman M, Segura A: The Spanish version of EuroQol: a description and its applications: European Quality of Life scale. Med Clin (Barc). 1999, 112: 79-85.","journal-title":"Med Clin (Barc)"},{"key":"451_CR34","first-page":"171","volume":"60","author":"JL V\u00e1zquez-Barquero","year":"1997","unstructured":"V\u00e1zquez-Barquero JL, Gaite L, Cuesta MJ, Garcia-Usieto E, Knapp M, Beecham J: Spanish version of the CSRI: a mental health cost evaluation interview. Arch Neurobiol (Madr). 1997, 60: 171-184.","journal-title":"Arch Neurobiol (Madr)"},{"key":"451_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/fampra\/cmi027","volume":"22","author":"A Patel","year":"2005","unstructured":"Patel A, Rendu A, Moran P, Leese M, Mann A, Knapp M: A comparison of two methods of collecting economic data in primary care. Family Pract. 2005, 22: 323-327. 10.1093\/fampra\/cmi027.","journal-title":"Family Pract"},{"key":"451_CR36","unstructured":"Now available at: Oblikue Consulting. Base de Datos de Costes Sanitarios eSALUD Barcelona. 2011"},{"key":"451_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0272989X0102100102","volume":"21","author":"X Bad\u00eda","year":"2001","unstructured":"Bad\u00eda X, Roset M, Herdman M, Kind P: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001, 21: 7-16. 10.1177\/0272989X0102100102.","journal-title":"Med Decis Making"},{"key":"451_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","volume":"3","author":"BA van Hout","year":"1994","unstructured":"van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C\/E-ratios alongside a clinical trial. Health Econ. 1994, 3: 309-319. 10.1002\/hec.4730030505.","journal-title":"Health Econ"},{"key":"451_CR39","doi-asserted-by":"crossref","DOI":"10.4135\/9781412983532","volume-title":"Bootstrapping: A Non-parametric Approach to Statistical Inference","author":"C Mooney","year":"1993","unstructured":"Mooney C, Duval R: Bootstrapping: A Non-parametric Approach to Statistical Inference. 1993, Sage, London"},{"key":"451_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hec.635","volume":"10","author":"E Fenwick","year":"2001","unstructured":"Fenwick E, Claxton K, Sculpher M: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001, 10: 779-787. 10.1002\/hec.635.","journal-title":"Health Econ"},{"key":"451_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1192\/bjp.187.2.106","volume":"187","author":"E Fenwick","year":"2005","unstructured":"Fenwick E, Byford S: A guide to cost-effectiveness acceptability curves. Br J Psychiatry. 2005, 187: 106-108. 10.1192\/bjp.187.2.106.","journal-title":"Br J Psychiatry"},{"key":"451_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i04","volume":"45","author":"P Royston","year":"2011","unstructured":"Royston P, White IR: Multiple imputation by chained equations (MICE): Implementation in Stata. J Stat Softw. 2011, 45: 1-20.","journal-title":"J Stat Softw"},{"key":"451_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB: Multiple Imputation for Nonresponse in Surveys. 1987, Wiley, New York"},{"key":"451_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB: Statistical Analysis with Missing Data. 2002, Wiley, New York"},{"key":"451_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/9780470510445","volume-title":"Missing Data in Clinical Studies","author":"G Molenberghs","year":"2007","unstructured":"Molenberghs G, Kenward MG: Missing Data in Clinical Studies. 2007, John Wiley & Sons Ltd, Chichester, West Sussex"},{"key":"451_CR46","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/ar2673","volume":"11","author":"A Sicras-Mainar","year":"2009","unstructured":"Sicras-Mainar A, Rejas J, Navarro R, Blanca M, Morcillo A, Larios R, Velasco S, Villarroya C: Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther. 2009, 11: R54-10.1186\/ar2673.","journal-title":"Arthritis Res Ther"},{"key":"451_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1192\/bjp.bp.111.107888","volume":"202","author":"C Mukuria","year":"2013","unstructured":"Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K, Parry G: Cost-effectiveness of an improving access to psychological therapies service. Br J Psychiatry. 2013, 202: 220-277. 10.1192\/bjp.bp.111.107888.","journal-title":"Br J Psychiatry"},{"key":"451_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.semarthrit.2011.06.003","volume":"41","author":"E Choy","year":"2011","unstructured":"Choy E, Marshall D, Gabriel ZL, Mitchell SA, Gylee E, Dakin HA: A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum. 2011, 41: 335-345. 10.1016\/j.semarthrit.2011.06.003.","journal-title":"Semin Arthritis Rheum"},{"key":"451_CR49","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/pme.12168","volume":"14","author":"RL Robinson","year":"2013","unstructured":"Robinson RL, Kroenke K, Williams DA, Mease P, Chen Y, Faries D, Peng X, Hann D, Wohlreich M, McCarberg B: Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the REFLECTIONS study. Pain Med. 2013, 14: 1400-1415. 10.1111\/pme.12168.","journal-title":"Pain Med"},{"key":"451_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","volume":"17","author":"F Wolfe","year":"2013","unstructured":"Wolfe F, Walitt BT, Katz RS, Lee YC, Michaud KD, H\u00e4user W: Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia. Eur J Pain. 2013, 17: 581-586. 10.1002\/j.1532-2149.2012.00234.x.","journal-title":"Eur J Pain"},{"key":"451_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1472-6963-8-128","volume":"8","author":"S Onrust","year":"2008","unstructured":"Onrust S, Smit F, Willemse G, van den Bout J, Cuijpers P: Cost-utility of a visiting service for older widowed individuals: randomised trial. BMC Health Serv Res. 2008, 8: 128-10.1186\/1472-6963-8-128.","journal-title":"BMC Health Serv Res"},{"key":"451_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.pain.2013.12.029","volume":"155","author":"JV Luciano","year":"2014","unstructured":"Luciano JV, Guallar JA, Aguado J, L\u00f3pez-Del-Hoyo Y, Olivan B, Magall\u00f3n R, Alda M, Serrano-Blanco A, Gili M, Garcia-Campayo J: Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study). Pain. 2014, 155: 693-702. 10.1016\/j.pain.2013.12.029.","journal-title":"Pain"},{"key":"451_CR53","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jpsychores.2013.10.010","volume":"75","author":"R Lauche","year":"2013","unstructured":"Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S: A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res. 2013, 75: 500-510. 10.1016\/j.jpsychores.2013.10.010.","journal-title":"J Psychosom Res"},{"key":"451_CR54","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar3002","volume":"12","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, Busch A: Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010, 12: R79-10.1186\/ar3002.","journal-title":"Arthritis Res Ther"},{"key":"451_CR55","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ: Fibromyalgia: a clinical review. JAMA. 2014, 311: 1547-1555. 10.1001\/jama.2014.3266.","journal-title":"JAMA"},{"key":"451_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/AJP.0b013e318164aa75","volume":"24","author":"RJ Smeets","year":"2008","unstructured":"Smeets RJ, Beelen S, Goossens ME, Schouten EG, Knottnerus JA, Vlaeyen JW: Treatment expectancy and credibility are associated with the outcome of both physical and cognitive-behavioral treatment in chronic low back pain. Clin J Pain. 2008, 24: 305-315. 10.1097\/AJP.0b013e318164aa75.","journal-title":"Clin J Pain"},{"key":"451_CR57","volume-title":"Cochrane Database Syst Rev","author":"C Eccleston","year":"2012","unstructured":"Eccleston C, Palermo TM, Fisher E, Law E: Psychological interventions for parents of children and adolescents with chronic illness. Cochrane Database Syst Rev. 2012, 8:"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0451-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0451-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:23:25Z","timestamp":1728923005000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0451-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0451-y","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]},"assertion":[{"value":"15 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"451"}}